Prevenar 13

BIOLOGICAL17 trials

Sponsors

GlaxoSmithKline, MCM Vaccines B.V., Pfizer, University of Oxford, Sanofi Pasteur, a Sanofi Company

Conditions

Acellular PertussisBacterial InfectionsBowel Diseases, InflammatoryChronic Lymphocytic LeukemiaCrohns DiseaseDiphtheriaHaemophilus Influenzae Type bHepatitis B

Phase 1

Safety and Immunogenicity of a 10 Valent Pneumococcal Conjugate Vaccine (SIILPCV10) in Healthy Adults, Toddlers, Infants

CompletedNCT02308540

PATHPneumococcal Disease

Start: 2015-01-12End: 2016-11-03Updated: 2019-08-02

Phase 2

Safety & Immunogenicity of Pneumococcal Vaccine 2189242A Co-administered With DTPa-HBV-IPV/Hib in Healthy Infants

CompletedNCT01204658

GlaxoSmithKlineInfections, Streptococcal

Start: 2010-09-27End: 2012-10-01Updated: 2019-05-29

Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744)

CompletedNCT01453998

GlaxoSmithKlineAcellular Pertussis, Diphtheria, Haemophilus Influenzae Type b +3

Start: 2011-10-14End: 2012-11-12Updated: 2020-07-17

Anti-pneumococcal Vaccine Strategy in Patients Treated With Immunosuppressants or Biotherapies for CIBD

TerminatedNCT02255227

Centre Hospitalier Universitaire de Saint EtienneBowel Diseases, Inflammatory, Infections, Pneumococcal

Start: 2015-04-13End: 2022-07-06Updated: 2023-06-15

A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella Disease and Typhoid Fever in Infants

Not yet recruitingNCT07286370

GlaxoSmithKlineSalmonella Infections

Start: 2026-02-16End: 2028-04-27Target: 537Updated: 2026-01-21

Phase 3

Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007)

CompletedNCT01341639

MCM Vaccines B.V.Bacterial Infections, Virus Diseases

Start: 2011-05-26End: 2013-03-13Updated: 2019-04-30

Pneumococcal Adult Kinetics Study - Understanding the B Cell Response to Pneumococcal Vaccines

CompletedNCT01432158

University of OxfordPneumococcal Disease

Start: 2012-01-31Updated: 2015-11-09

An Efficacy Study of GlaxoSmithKline (GSK) Biologicals' Candidate Influenza Vaccine GSK2321138A in Children

CompletedNCT01439360

GlaxoSmithKlineInfluenza

Start: 2011-10-01End: 2014-12-31Updated: 2018-09-26

Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster Vaccination

CompletedNCT01839175

Sanofi Pasteur, a Sanofi CompanyBacterial Infections, Neisseria Meningitidis, Virus Diseases

Start: 2013-04-30End: 2015-02-28Updated: 2017-09-11

Pneumococcal Vaccine in Untreated CLL Patients

CompletedNCT01892618

Karolinska University HospitalChronic Lymphocytic Leukemia

Start: 2013-08-31End: 2015-12-31Updated: 2016-01-15

VACcination In Methotrexate Treated Rheumatoid Arthritis Patients

CompletedNCT01942174

University Hospital, MontpellierRheumatoid Arthritis

Start: 2013-09-27End: 2019-07-10Updated: 2020-08-03

This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized Vaccine

CompletedNCT03207750

GlaxoSmithKlineRotavirus Infection, Rotavirus Vaccines

Start: 2017-09-14End: 2019-03-01Updated: 2020-12-29

Study of 10-valent Pneumococcal Conjugate Vaccine (Pneumosil) Administered in a 2+1 Schedule to Healthy Infants

CompletedNCT03896477

PATHPneumonia, Pneumococcal

Start: 2019-07-18End: 2020-12-17Updated: 2022-04-20

Phase III Clinical Trial of 13-valent Pneumococcal Conjugate Vaccine (Multivalent Conjugate) in Infants

Active, not recruitingNCT05759520

Fosun Adgenvax Biopharmaceutical Co.,Ltd.Streptococcus Pneumoniae Infection

Start: 2022-11-04End: 2025-06-30Target: 1800Updated: 2024-10-01

Phase 4

Pneumococcal Vaccination of Crohn Patients

CompletedNCT01947010

Statens Serum InstitutCrohns Disease

Start: 2013-07-31End: 2014-08-31Updated: 2015-02-10

Pneumococcal Vaccination to Accelerate Immune Recovery in Sepsis Survivors

CompletedNCT03565159

Guy's and St Thomas' NHS Foundation TrustSepsis

Start: 2018-08-02End: 2023-08-31Updated: 2023-11-24

Unknown Phase

Safety Surveillance of Pneumococcal 13-valent Conjugate Vaccine Among Filipinos

CompletedNCT01396434

PfizerPneumococcal Disease

Start: 2011-12-31End: 2014-05-31Updated: 2017-01-30

Related Papers

Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial.

2025-07-29

Immunogenicity and safety of a 10-valent pneumococcal conjugate vaccine administered as a 2 + 1 schedule to healthy infants in The Gambia: a single-centre, double-blind, active-controlled, randomised, phase 3 trial.

2023-01-108 citations

Association Between Hemagglutination Inhibition Antibody Titers and Protection Against Reverse-Transcription Polymerase Chain Reaction–Confirmed Influenza Illness in Children 6–35 Months of Age: Statistical Evaluation of a Correlate of Protection

Open Forum Infectious Diseases2021-09-258 citations

Concomitant administration of a liquid formulation of human rotavirus vaccine (porcine circovirus-free) with routine childhood vaccines in infants in the United States: Results from a phase 3, randomized trial.

2020-10-172 citations

1385. Concomitant Administration of Liquid Porcine Circovirus-free Human Rotavirus Vaccine with Routine Pediatric Vaccines Does Not Impact Immune Responses in Infants: Results from a Phase 3, Randomized Trial in the United States

Open Forum Infectious Diseases2020-10-01

Safety and immunogenicity of a novel 10-valent pneumococcal conjugate vaccine candidate in adults, toddlers, and infants in The Gambia—Results of a phase 1/2 randomized, double-blinded, controlled trial

Vaccine2019-12-1430 citations

Persistence of antibodies to pneumococcal conjugate vaccine compared to polysaccharide vaccine in patients with Crohn’s disease – one year follow up

Infectious Diseases2019-07-1010 citations

Concomitant administration of a fully liquid ready-to-use DTaP-IPV-HB-PRP-T hexavalent vaccine with a meningococcal ACWY conjugate vaccine in toddlers

Vaccine2018-11-2212 citations

Anamnestic Immune Response and Safety of an Inactivated Quadrivalent Influenza Vaccine in Primed Versus Vaccine-Naïve Children

The Pediatric Infectious Disease Journal2018-10-164 citations

Immunogenicity and safety of 11- and 12-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccines (11vPHiD-CV, 12vPHiD-CV) in infants: Results from a phase II, randomised, multicentre study

Vaccine2018-07-2517 citations

Safety, reactogenicity and immunogenicity of two investigational pneumococcal protein-based vaccines: Results from a randomized phase II study in infants.

2017-07-1717 citations

Immunogenicity and safety of primary and booster vaccination with 2 investigational formulations of diphtheria, tetanus and<i>Haemophilus influenzae</i>type b antigens in a hexavalent DTPa-HBV-IPV/Hib combination vaccine in comparison with the licensed<i>Infanrix hexa</i>

Human Vaccines & Immunotherapeutics2017-03-241 citations

A Phase III Randomized, Double-blind, Clinical Trial of an Investigational Hexavalent Vaccine Given at Two, Three, Four and Twelve Months.

2017-02-0122 citations

Concomitant administration of a fully liquid, ready-to-use DTaP-IPV-HB-PRP-T hexavalent vaccine with a meningococcal serogroup C conjugate vaccine in infants.

2016-12-099 citations

Immunosuppressive drugs impairs antibody response of the polysaccharide and conjugated pneumococcal vaccines in patients with Crohn's disease.

2015-08-1236 citations